Current globally harmonized Organisation for Economic Cooperation and Development (OECD) animal test guidelines for developmental toxicity require high numbers of experimental animals. To reduce animal use in this field, alternative developmental toxicity assays are highly desirable. We previously developed a dynamic in vitro model for screening effects of possible neurodevelopmental toxicants, using neural cell differentiation of pluripotent murine embryonic stem cells. To further mechanistically characterize the mouse neural embryonic stem cell test (ESTn) and to improve detection of possible neurodevelopmental toxicants, gene expression patterns were studied describing neural cell differentiation over time, as well as the impact on gene expression of exposure to the well-known neurotoxicant methylmercury (MeHg). A transcriptomics study was performed to examine whole-genome expression changes during the first 7 days of the cell differentiation protocol. Specific gene clusters were identified and enrichment analysis of Gene Ontology (GO) terms and gene sets derived from literature was performed using DAVID and T-profiler. Over time, a decrease of blastocyst and trophectoderm GO terms was observed, which included well-characterized pluripotency genes. Furthermore, an increase in the range of neural development-related GO terms, such as neuron differentiation and the wnt pathway, was observed. Analysis of gene expression using principle component analysis showed a time-dependent track in untreated cells, describing the process of neural differentiation. Furthermore, MeHg was shown to induce deviation from the predefined differentiation track. The compound inhibited general development GO terms and induced neural GO terms over time. This system appears promising for studying compound effects on neural differentiation in a mechanistic approach.
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The new European chemical safety regulation (Regulation, Evaluation, and Authorization of Chemicals [REACH])
requires many compounds to be tested. Current chemical hazard assessment for developmental toxicity is built upon globally harmonized Organisation for Economic Co-operation and Development (OECD) animal test guidelines, providing a structure for chemical risk assessment and in addition encouraging the development of alternative testing strategies. Under REACH guidelines,~60% of all animals will be used for reproductive and developmental toxicity studies (van der Jagt et al., 2004) . In order to reduce the number of experimental animals needed for developmental toxicity testing, cell-based alternative test methods are being developed, such as embryonic stem cell (ESC) tests studying multiple differentiation lineages Theunissen et al., 2010; zur Nieden et al., 2010) , the whole-embryo culture (WEC; Piersma et al., 2004) , and the zebrafish embryo test (Hermsen et al., 2011; Nagel, 2002) . A common target for developmental toxicity is the developing nervous system. Classical developmental toxicants, such as methylmercury (MeHg), valproic acid, and ethanol, particularly target neural development resulting in neural tube defects (NTDs), craniofacial malformations, mental retardation, and fetal alcohol syndrome (Alsdorf and Wyszynski, 2005; Faustman et al., 2002; Welch-Carre, 2005) . To specifically examine known and unknown neurodevelopmental toxic compounds, in vitro test systems are being developed which mimic and/or partially represent nervous system development in vivo (Costa et al., 2007; Shafer et al., 2002; Stummann et al., 2007; Theunissen et al., 2010; Walum and Flint, 1990) . In particular, ESC provide a promising in vitro model for neural differentiation as they can be differentiated into multiple lineages of neural and other brain-associated cells (Bibel et al., 2004; Okabe et al., 1996) . In our previous study using mouse embryonic stem cells (mESC; Theunissen et al., 2010) , we designed an abbreviated 13-day neural differentiation protocol to examine the effects of neurodevelopmental toxic compounds. Using the classical neurodevelopmental toxicant MeHg, we demonstrated the ability to examine the potential for neurodevelopmental toxicity based on morphological scoring of neural outgrowth from stem cellderived embryoid bodies (EB).
Although this test system and others show promise in being used for the prediction of neurodevelopmental toxicity, current criteria in assessing neurodevelopmental toxicity take into account limited end points of toxicity, such as cell morphology (neural outgrowth, cytotoxicity, and migration; Mundy et al., 2010; Radio and Mundy, 2008) , functional parameters determined by electric potential (Shafer et al., 2002) , or RNA transcripts of a small selected number of genes (Stummann et al., 2007) . The complexity of the developing nervous system warrants a more comprehensive assessment at the molecular level of exposure effects by neurodevelopmental toxicants. Currently, emerging genomic technologies such as transcriptomics, which can be employed to assess effects on the wholegenome level are being implemented into in vitro and in vivo neurotoxicological studies (Robinson et al., 2010a (Robinson et al., , 2010b (Robinson et al., , 2010c . The assessment of multiple end points both at the level of gene expression as well as considering molecular pathways is expected to provide a robust mechanistic approach to analyze and predict toxicity (Krewski, 2007; Nemeth et al., 2005; van Dartel et al., 2010a van Dartel et al., , 2010b van Dartel et al., , 2011 . To improve detection of developmental neurotoxicity and mechanistic understanding in the neural embryonic stem cell test (ESTn) model, a transcriptomics study was performed to assess the regular gene expression changes in unexposed differentiating ESC cultures. Furthermore, we studied the impact of the developmental toxicant MeHg on gene expression changes overtime. During the past century, catastrophic MeHg poisonings in Japan and Iraq have shown its neurodevelopmental toxicity (Cox et al., 1989; Davidson et al., 2004) . Since then, MeHg has become a well-characterized and widely used model compound for neurodevelopmental toxicity (Burbacher et al., 1990; Myers and Davidson, 1998) .
In the present study, transcriptomics analysis over time of early differential gene expression appeared to provide a robust method to monitor ultimate neural differentiation in the ESTn model. In addition, MeHg was shown to affect neurodevelopmental and proliferation-related gene pathways in association with affected neural differentiation, illustrating the added value of transcriptomics analysis of neural cell differentiation in vitro for the detection of developmental neurotoxicants and the study of developmental toxicity mechanisms of action.
MATERIALS AND METHODS
Culture media. Complete medium (CM) contained Dulbecco's modified Eagle's medium (DMEM; Gibco BRL, Gaithersburg, MD) supplemented with 20% fetal bovine serum (Hyclone, Logan, UT), 1% nonessential amino acids (Gibco BRL), 1% penicillin/streptomycin (Gibco BRL), 2mM L-glutamine (Gibco BRL), and 0.1mM b-mercaptoethanol (Sigma-Aldrich, Zwijndrecht, The Netherlands). Low-serum (LS) medium had the same composition as CM except that the serum percentage is 10%. Insulin-transferrin-selenite-fibronectin (ITS) medium contained DMEM/Ham's nutrient mixture F12 (DMEM/F12) medium (Gibco BRL) supplemented with 0.2 lg/ml bovine insulin (Sigma-Aldrich), 1% Penicillin/Streptomycin (Gibco BRL), 2mM L-glutamine (Gibco BRL), 30nM sodium selenite (Sigma-Aldrich), 50 lg/ml apo-transferrin (Sigma-Aldrich), and 2.5 lg/ml fibronectin (Invitrogen, Carlsbad, CA) . N 2 medium contained DMEM/ F12 medium (Gibco, BRL) supplemented with 0.2 lg/ml bovine insulin (SigmaAldrich), 1% penicillin/streptomycin (Gibco BRL), 30nM sodium selenite (Sigma-Aldrich), and 50 lg/ml apo-transferrin (Sigma-Aldrich).
Embryonic stem cell culture. Murine ESC (ES-D3; ATCC, Rockville, MD) were routinely subcultured every 2-3 days and grown as a monolayer in CM supplemented with leukemia-inhibiting factor (Chemicon, Temecula, CA) at a final concentration of 1000 units/ml. The cells were maintained in a humidified atmosphere at 37°C and 5% CO 2 .
Neural differentiation culture. Differentiation of murine ESC into the neural lineage was carried out as described earlier (Theunissen et al., 2010) . In brief, stem cell suspensions (3.75 3 10 4 cells/ml) were placed on ice before the initiation of the culture. Drops (20 ll) containing 750 cells in CM were placed onto the inner side of the lid of a 90-cm petri dish filled with PBS (Gibco BRL) and incubated at 37°C, 90% relative humidity, and 5% CO 2 . After 3 days of hanging drop culture, EB had formed and were subsequently transferred to 60-mm bacterial petri dishes (Greiner Bio-one, Frickenhausen, Germany) containing CM supplemented with 0.5lM retinoic acid (RA). On day 5, EB were plated on laminin (Roche, Basel, Switzerland)-coated dishes (Corning Incorporated, Corning, NY) in LS medium supplemented with 2.5 lg/ml fibronectin (Invitrogen). One day later, on day 6, the LS medium was replaced by ITS medium. On day 7, EB were washed with PBS (Gibco BRL) and incubated in cell dissociation buffer (Gibco BRL) for 3 min. Then EB were carefully detached from each petri dish without dissociating the EB, and the entire content was replated on poly-L-ornithine (Sigma-Aldrich) and laminincoated dish in N 2 medium supplemented with 10 ng/ml basic fibroblast growth factor (bFGF; Srtathmann-Biotec AG, Englewood, CO). The N 2 medium supplemented with bFGF was replaced every day for 7 days ( Fig. 1 ).
Treatment and morphological scoring for effects on neural outgrowth. Methylmercury chloride (CAS number 115-09-3; Sigma-Aldrich) was diluted in dimethyl sulfoxide (DMSO) and added to the medium to final concentrations in culture of 25nM MeHg, and control EB were treated with 0.01% DMSO as described earlier from day 3 of the protocol until day 11 (Theunissen et al., 2010) . This concentration of MeHg did not affect cell viability in the model. Effects were determined by assessing the morphological extent of neural outgrowth, at day 11, observed using an IX51 inverted microscope (Olympus, Zoeterwoude, The Netherlands) with CellD software (Olympus). Morphological neural outgrowth was scored as < 75 or ! 75% of the neural corona surrounding each EB, irrespective of the distance of outgrowth from the EB. Parallel cultures were harvested for gene expression analysis at earlier time points.
RNA isolation and whole-genome expression profiling. Control differentiation cultures were harvested on culture days 0, 3, 4, 5, 6, and 7 (eight replicates per group). Methylmercury chloride-exposed differentiation cultures were exposed from day 3 onward and harvested on days 4, 5, 6, and 7 (24, 48, 72 , and 96 h exposure, respectively; eight replicates per group; Fig. 1 ). Cells (~40 to 50 EB/sample) were directly collected in RNA Protect (Qiagen Benelux, Venlo, The Netherlands) to stabilize RNA, and total RNA was purified using the Qiagen RNEasy Plus Mini Kit (Qiagen Benelux) following manufacturers' instructions. RNA quantity was determined using the NanoDrop Spectrophotometer (Isogen Lifescience, de Meern, The Netherlands). RNA integrity was assessed on the 2100 Bioanalyzer (Agilent, Santa Clara, CA) using the RNA 6000 Nano Chip Kit (Agilent), and good quality RNA was used for gene expression analysis (RNA integrity number > 8.0). Labeled antisense amplified RNA (aRNA) target was generated by using the Affymetrix genechip (Affymetrix, Santa Clara, CA; 3#IVT express kit 4 3 24 reactions, P/N 901225), according to the instructions in the users manual. Briefly, 250 ng of each total RNA sample and also controls were used to prepare first-strand complementary DNA (cDNA). After making the complementary second strand, the double-stranded cDNA is amplified by in vitro transcription (IVT). During 438 THEUNISSEN ET AL.
this IVT reaction, a biotinylated nucleotide analog is incorporated in the aRNA. This IVT reaction was followed by aRNA purification with magnetic beads and fragmentation (15 lg) of each aRNA sample. The whole process from first-strand cDNA synthesis till fragmentation of the aRNA was performed by the Xiril Neon 150 robotic system (GC-Biotech, Alphen aan den Rijn, The Netherlands).
After fragmentation, a 250-ll hybridization cocktail with 12.5 lg of fragmented aRNA was prepared; 200 ll of this cocktail (10 lg aRNA target) was applied to the Mouse Genome 430 2.0 arrays (P/N 900497; Affymetrix) and hybridized for 16 h at 45°C in a Genechip Hybridization Oven 640. After hybridization, the arrays were washed and stained with a Genechip Fluidics Station 450 using the Affymetrix genechip hybridization wash and stain kit (P/N 900720). Washed and stained arrays were scanned using the genechip scanner 3000 from Affymetrix. Hybridization was performed at Affymetrix.
Data analysis and statistics. Affymetrix CEL files were normalized using the Robust Multichip Average (RMA) algorithm using RMAexpress (Bolstad et al., 2003 (Dai et al., 2005) and 4648 additional probe sets defined by Affymetrix chip annotation 26 were used in further analyses, giving a total of 20,979 probe sets. Probe sets for Affymetrix internal controls or probe sets that did not correspond to an Entrez Gene ID were not used in further analyses. Statistical analyses were carried out using the R statistical software environment (http://www.R-project.org) using logtransformed values. For each gene, maximal fold ratios (FR) in gene expression between the experimental groups were determined by comparing the average normalized signal values per group and were calculated as the maximum/ minimum ratio. For the time series, expression of a gene was compared with the median expression of all samples. For MeHg toxicity effects, the treated samples were compared with the time-matched controls. Genes differentially expressed between any of the experimental groups were identified by a oneway ANOVA on the normalized data. A significance threshold of p < 0.001 and FR > 2 were used to select genes that were significantly differentially expressed when ESC differentiate overtime. A p < 0.001 with FR > 1 restriction was applied for the identification of significantly differentially expressed genes caused by MeHg exposure. Hierarchical clustering of genes significantly differentially expressed over time in the neural differentiation cultures was performed in GeneMaths XT (Applied Maths, Sint-MartensLatem, Belgium), using Euclidean distance and Ward linkage. Functional annotation and enrichment for Gene Ontology (GO) biological processes and KEGG pathways were studied using the tools on the DAVID Web site (http:// david.abcc.ncifcrf.gov/) (Huang et al., 2007) . Terms with a p < 10 À4 and a Functional Annotation Clustering Enrichment Score > 3 were considered enriched, and if terms clustered together, the most significant functional term within that cluster was used. For pathway-level analysis, each gene was corrected for its average across all time points, after which T-Profiler (Boorsma et al., 2005) was used to score the difference between the mean expression level of predefined groups of genes (e.g., GO terms or literature-based gene sets) and that of the remainder of the 20,979 probesets defined earlier. Gene sets were significantly regulated, if T > 3.5 and E >0.05. The T value is the value obtained by a t-test between the expression changes for a defined set of genes versus all other genes. The corresponding formula and other calculation details can be found in Boorsma et al. (2005) . The E value is the associated two-tailed p value with Bonferroni correction for the number of gene sets tested. Literature gene sets were derived from Kuegler et al. (mESC and neural stem cell [NSC] gene sets; Kuegler et al., 2010) and the GNF1M Gene Atlas data set described by Su et al. (2004) (downloaded from Gene Expression Omnibus (GEO), accession number GSE1133) describing mouse tissue-specific gene sets. To correct for overlap between tissue-specific gene sets, forward selection was performed. In short, the gene set with the highest absolute t value is used, and the mean contribution of each gene in the set is subtracted from all genes in the gene set. Then a new t value is calculated with the changed values, and the same process is repeated until no significant gene sets are found. The gene expression over time and the effect of MeHg on gene expression was further studied using principle component analysis (PCA) by means of the differentiation track algorithm, an approach based on PCA (Pearson, 1901) . In this analysis, a principal component is defined as a mathematically derived combination of genes and their expression characteristics, which can be used to depict part of the process observed. A number of principal components that are mutually independent can be derived, which in combination describe the process under study. For the differentiation track algorithm, at first a gene list was defined, which comprised the genes that were identified to be significantly differentially expressed among ESC differentiation sampled at different stages over time. Next, PCA analysis was performed using these genes using R. We connected a line among the average array gene expression at days 0, 3, 4, 5, 6, and 7 on our PCA plot to display the continuous representation of the ESC
FIG. 1.
Hanging drops containing ESC were made on day 0. Single cells formed EB. On day 3, the EB were transferred to suspension medium supplemented with 0.5lM all-trans-RA. On day 5, EB were plated on laminincoated dishes and kept in medium containing 10% serum. On day 6, the medium was replaced with a serum-free medium (ITS). On day 7, EB were detached from the dish and replated on PLO/laminin-coated dishes and N 2 medium was added. On day 11, morphological scoring for neural outgrowth was performed. MeHg treatment was started on day 3 of the protocol, and treated samples were collected after 24, 48, 72, and 96 h exposure (n ¼ 8 per group). Control samples were collected on days 0, 3, 4, 5, 6, and 7 (n ¼ 8 per group).
MeHg TRANSCRIPTOMICS IN ESTn 439 differentiation over time based on the dynamics of gene expression. This curve was defined as the 'differentiation track' overtime. For describing the effects of MeHg on the track at a particular day, a comparison was made with a differentiation track derived on the basis of genes showing differential expression between the day before, the same day, and the day after the time point analyzed. Limiting the analysis to genes that show time-related expression in the protocol avoided the contribution of genes not regulated during neural development in the protocol. Coordinates along the first and second principal components were calculated for each sample. Deviation of compound-exposed cultures from the differentiation track was analyzed by applying a Hotelling t-test to these coordinates compared with those of timematched control cultures. Significant deviation from the differentiation track (p < 0.05) was considered characteristic for developmental toxicants. Genes significantly changed (p < 0.001, FR > 2.0) in the period of the 3 days surrounding the specific treatment day of interest were used to set up the track, and the gene expression of the MeHg samples was placed in the track.
RESULTS

ESC (Neural) Differentiation Is Accompanied by Gene
Expression Changes Over Time We identified 4393 genes which were significantly differentially expressed (p < 0.001 and FR > 2) in control cultures across time (days 0, 3, 4, 5, 6, and 7). Eight gene clusters (A-H) were defined by hierarchical clustering (Euclidean distance, ward linkage) on the basis of expression dynamics over time ( Figs. 2A and 2B) . Cluster A showed a high gene expression early (day 0) and later in time (days 6 and 7), but low expression on days 3-5. Due to the small amount of genes present in this cluster, no significant (p < 1 3 10 À4 ) GO terms were found. Genes in cluster B were mainly increased at early time points (days 0 and 3). GO terms enriched within this cluster were associated with transcription (nucleolus, rRNA, tRNA, and DNA metabolic process), cell metabolism (mitochondrion), and pluripotency (blastocyst formation and trophectoderm cell differentiation). Highly upregulated genes in this cluster (FR > 16) included the pluripotency-related genes Pou5f1 and Nodal (Niwa et al., 2000; Ogawa et al., 2007) . In cluster C, genes were mainly increased on day 3 and in GO terms involved in early development (pattern specification, embryonic morphogenesis, and blastocyst, mesoderm, and endoderm-related clusters) and cell migration. Cluster D was increased on days 4 and 5. Due to the small amount of genes present in set D, no significant (p < 1 3 10 À4 ) GO terms were found. In cluster E, genes were increased from day 4 onward and expression increased over time. This cluster was enriched for the Wnt signaling pathway and TGF-b signaling pathway, both important in development. In addition, a broad range of developmental GO terms was enriched (neuron development, tube development, skeletal development, vasculature development, limb development, and urogenital system development). Cluster F genes were mainly increased on days 6 and 7, and genes in cluster G were mainly increased over time from days 4, 5, 6, and 7 and relatively low on day 0. Cluster H genes were low expressed on days 0 and 3 and highly increased on days 5, 6 and most on day 7. A high overlap was observed for GO terms enriched in clusters F, G, and H, which consisted mainly of neural associated GO terms (neuron differentiation, fate commitment, and migration), and other development-related GO terms (pattern specification, skeletal development, inner ear development, and eye development). In the enriched neuron differentiation GO term, many markers known to play a critical role in neuronal development were highly (FR > 16) induced, such as Pax6, Tubb3, and Nefl (Liu et al., 2007; Moskowitz and Oblinger, 1995) .
ESC (Neural) Differentiation Cultures Express TissueSpecific Gene Sets
Gene sets for embryonic days 8.5, 9.5, and 10.5 were extracted from GEO, and mouse tissue-specific gene sets were analyzed in T-profiler to determine the most prominent tissues developing over time in our neural differentiation protocol (Fig. 2C) . Embryonic day 8.5 showed an increase in gene expression from day 4 onward, peaking on day 5 and a decrease in gene expression from day 6 onward. Embryonic day 9.5 showed a similar expression profile compared with embryonic day 8.5, but with a higher t value and significance. The first significant increase for the embryonic day 10.5 set was observed on day 5, and the expression further increased on days 6 and 7. Over time, gene sets representing very early development (blastocyst and oocyte) were induced on day 0 and their expression diminished overtime. Furthermore, sets important during the postimplantation period (placenta and umbilical cord) were increased from day 5 onward. Gene sets of tissues derived from the ectodermal lineage (different regions of the brain and spinal cord) were starting to increase on day 6 and were strongly increased on day 7. Regarding the endodermal derived tissues, expression for lung was decreased significantly only on day 4, and gene expression for the small intestine and salivary gland was not significantly regulated over time. Furthermore, the gene sets describing mesodermal derived kidney and testis were reduced from day 6 onward.
Neural Differentiation Culture Shows a Time-Dependent
Change in PCA PCA was performed on control samples (days 0, 3, 4, 5, 6, and 7) using the 4393 genes differentially expressed overtime (Fig.  2D) ; 76% of the variance could be assigned to the first (60%) and second (16%) principle components of the PCA. Groups of each time point clustered together, forming a chronological representation of neurological differentiation, which we will refer to as the 'differentiation track ' (van Dartel et al., 2010b) .
Morphological Scoring Shows MeHg Effects
As described earlier (Theunissen et al., 2010) , MeHg (25nM, exposure from day 3 to 11) resulted in a significant decrease in neural outgrowth as compared with concurrent controls. MeHg-exposed samples showed a 63% (± 10%) decrease of EB with > 75% outgrowth around the EB. 
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MeHg Increases Expression of Neural Development-Related
Genes Gene expression changes in cultures treated with MeHg (treatment from day 3 onward for 24, 48, 72, and 96 h) were compared with their time-matched control on days 4, 5, 6, and 7 by a one-way ANOVA (p < 0.001 and FR > 1.0). After 24 h treatment, 490 genes were significantly regulated, after 48 h treatment, 6 genes, after 72 h, 29 genes, and after 96 h, 97 genes were significantly regulated. In total, 611 genes were significantly differentially regulated by MeHg over time. Clustering of these genes showed predominantly a group downregulated over time and a group upregulated over time (Fig. 3A) . Analysis using DAVID showed that the downregulated group had significant changes in transcription-and embryonic development-related terms. The upregulated group showed significant enrichment for cell motion and neuron development terms.
MeHg Increases Late Differentiation Genes and Decreases Early Differentiation Genes
Gene set clusters derived from neural differentiation overtime ( Fig. 2A, clusters A-H) and clusters describing mESC and NSC gene expression were used to study the effect of MeHg with T-profiler (Fig. 3B) . A significant increase in gene expression by MeHg at most time points was observed in the late time clusters (E, F, G, and H) and in the NSC set. In set A, only on day 6, a small significant increase in expression was observed. In contrast, the early time clusters (B, C, and D) and the mESC set were significantly downregulated by MeHg at most time points.
MeHg Increases Neuroectodermal Gene Sets and Decreases
Developmental, Mesodermal, and Endodermal Derived Tissue Gene Sets
Mouse tissue-specific gene sets were analyzed in Tprofiler to determine the most important tissues affected by MeHg compared with time-matched controls (Fig. 3C) . Gene sets associated with very early development were downregulated by MeHg as was the placenta gene set. Gene sets of specific embryonic days showed a decrease in average gene expression by MeHg in early embryonic days (6.5 and 7.5). The embryonic day 8.5 only showed a significant decrease on days 6 and 7 and embryonic day 10.5 showed a significant increase on day 5. No significant changes were observed for the embryonic day 9.5 gene set (data not shown). In contrast, gene sets of tissues related to neuroectoderm were significantly increased by MeHg on days 6 and 7 and in a few cases also on day 4. Nonneural ectodermal gene sets (retina and snout epidermis) showed no differences or a small decrease. Expression of mesodermal and endodermal genes was predominantly decreased on day 7.
MeHg-Exposed Cultures Deviate Over Time from the Neural Differentiation Track
The effect of MeHg on gene expression was further studied using PCA by means of the differentiation track algorithm. Genes significantly regulated in controls ''day 3/4/5'' (1509 genes), ''day 4/5/6'' (782 genes), and ''day 5/6/7'' (586 genes) were compared with gene expression after exposure to MeHg as assessed on days 4, 5, and 6, respectively. MeHg treatment measured on day 4 deviated significantly from the track (p ¼ 0.0008) (Fig. 4A) , but MeHg measured on day 5 (p ¼ 0.19; Fig. 4B ) and day 6 (p ¼ 0.08; Fig. 4C) were not significantly different as compared with their control 3-day differentiation track.
DISCUSSION
ESC Neural Differentiation and Gene Expression Changes
Over Time Transcriptomics analyses were instrumental in the description of the neural differentiation process of ESC ( Figs. 2A and  2B) , showing a reduction of pluripotency and an induction of neural differentiation-related gene sets over time. In addition, two gene clusters (C and D) were found to be transiently regulated at days 3 and 4 of the ESTn protocol, respectively. Gene clusters behaving similarly were observed in gene expression profiles overtime for the cardiac embryonic stem cell test (ESTc) (van Dartel et al., 2010b) . A number of the top regulated genes (FR > 16) in ESTn gene cluster D are involved in RA metabolism and brain development, such as Cyp26a1 (Abu-Abed et al., 2001). It has been suggested that genes in these clusters could be important in the early stages of differentiation (van Dartel et al., 2010b) . The differentiation processes observed over time were reminiscent of the developmental pathways observed in the embryo in a similar time dependency (Fig. 2C ) and showed clear germline specificity for induction of neurodevelopmental pathways. Furthermore, the differentiation process within the ESTn over time could be visualized in a two-dimensional PCA plot (Fig. 2D) . Our results support the observations of neuronal differentiation and the loss of pluripotency in the ESTn over time described earlier (Theunissen et al., 2010) and provide a more detailed mechanistic assessment of the dynamic changes underlying neural development in the model. Previously, genomics studies using a broad variety of mESC neural differentiation culture techniques and time points (Abranches et al., 2009; Kim et al., 2009; Zimmer et al., 2010) described similar changes in expression of genes as observed in our study. For instance, Abranches et al. (Abranches et al., 2009 ) described comparable regulated genes at time points which correspond to the ESTn protocol (early differentiation genes Frzb, Id2, and Lrp2, late differentiation genes Pax6, Neurog1, Nhlh1, Notch1, and Lx9). Furthermore, gene expression profiles in our study correspond to published mouse in vivo developmental gene sets describing early neural differentiation. Mitiku and Baker (2007) the mouse transcriptome of gastrulation through organogenesis from E6.25 to E9.0. One of the specific clusters they identified was highly enriched for neural development-related GO terms. The expression profile of the clusters F-H in our study correspond with the gene expression profile found in the cluster described by Mitiku and Baker (72 of 227 genes), with enriched GO terms for neural development, neuron migration, axiogenesis, and axon guidance, among others. Analysis of the cluster defined by Mitiku and Baker in T-profiler on our time data showed an increase in expression from day 4 to day 7. Therefore, ESTn transcriptomics shows an extensive correlation with morphological neurodevelopment while providing a more detailed assessment of dynamic changes in gene expression and the associated functional processes over time.
MeHg-Induced Gene Expression Changes Over Time in
Neural Differentiating ESC MeHg exposure resulted in downregulation of transcriptionand development-related genes and in upregulation of neurodevelopment and cell motion-related gene sets (Figs. 3A and 3B) . MeHg retarded embryonic development as observed by stage-specific gene expression but specifically increased the expression of neural differentiation gene sets (Fig. 3C) . The relatively small gene expression changes early in the protocol as compared with the more robust morphological effects observed at the end of the protocol is probably related to the difference in timing of both parameter types. The molecular mechanisms behind MeHg neurodevelopmental toxicity have currently not been identified, but in vivo and in vitro studies have suggested mechanisms involving oxidative stress, cell cycle regulatory proteins, protein phosphorylation, and intracellular calcium homeostasis (Ceccatelli et al., 2010; Faustman et al., 2002) . In our previous study focusing on protein and cellular effects, MeHg inhibited mESC neurite growth and migration and at higher concentrations, increased the neural precursor marker protein nestin (Theunissen et al., 2010) . In another study, MeHg was shown to decrease the expression of the neuron-specific cytoskeletal protein Mtap2 gene expression after 14 days of mESC neural differentiation at a concentration of 100nM (Stummann et al., 2007) . Studies describing MeHg developmental toxicity using genomics in mouse embryos undergoing neurulation (Robinson et al., 2010a (Robinson et al., , 2010b and the rat WEC (Robinson et al., 2010c) showed upregulation of early neural differentiation gene sets associated with neurodevelopmental malformations observed subsequently. In vivo studies showed that 8 and 12 h after MeHg exposure in utero, neural developmental pathways, such as the wnt signaling pathway (Robinson et al., 2010b) , were upregulated at dose levels which were associated with NTDs and other malformations (Spyker and Smithberg, 1972) . In the rat WEC study (Robinson et al., 2010c) , MeHg induced neural gene expression upregulation at 4 h in association with multiple developmental defects at 48 h (NTDs and effects on yolk sac, branchial bar, eye, mandibular, heart, and limb). These observations from three different models indicate that upregulation of neurodevelopmental genes at an early time point was related to impaired morphological development at a later time point.
Differentiation Track Analysis of Neurodevelopmental
Toxicity Effects in ESTn Specific manifestations of developmental toxicity at the morphological level can be caused by diverse effects on the gene expression level, representing different mechanisms of toxic action (Robinson et al., 2010a) . Studying individual genes or proteins in stem cell differentiation assays gives only limited information about mechanisms of action of compounds (Pellizzer et al., 2004; Stummann et al., 2007; Theunissen et al., 2010) . Larger sets of functionally related genes may help to further clarify mechanisms of neurodevelopmental toxicity. In previous studies using the ESTc, van Dartel et al. (2009 used the differentiation track method to determine compound toxicity in a temporal manner. In the present study, we used the time-related differentiation track method (van Dartel et al., 2010b) to study gene expression over time. The effects of MeHg on cell differentiation were determined through the deviation of the treated samples from the differentiation track. Analysis of 3-day differentiation tracks revealed that the 24-h exposure time point gave the most significant deviation from the differentiation track after MeHg exposure, whereas 48 and 72 h exposure samples did not deviate significantly from the track. This may be due to increasing sample variance overtime, both in controls and treated samples, as well as to the fact that in the PCA plot the 24-h time point showed the highest dynamics in gene expression changes as compared with the remaining time points (Figs. 2D and 4A-C) . Furthermore, the largest number of significantly regulated genes by MeHg exposure was observed at this time point, including many genes also regulated by time. Earlier studies with ESTc determined the same optimal time point for studying compound effects and for similar reasons (van Dartel et al., 2010a) . In the classic ESTc, MeHg developmental toxicity was misclassified using the classical prediction model of the European Centre for Validation of Alternative Methods validation study (Genschow et al., 2002) and, depending on the predicting gene sets used, was borderline or not identified as a developmental toxicant in the same test system with transcriptomics analysis using the differentiation track (van Dartel et al., 2011) . In the present study, we clearly showed a significant deviation of MeHg-treated samples on the differentiation track after 24 h exposure at a lower tested concentration, indicating that the ESTn is more sensitive for detecting MeHg-induced developmental toxicity as compared with the ESTc. This is in line with the developmental toxic properties of MeHg which are primarily neurodevelopmental in nature (Ceccatelli et al., 2010; Faustman et al., 2002) .
In this study, we described the process of neural differentiation in our ESC model at the whole-genome level. Using multiple types of analysis, pluripotency was found to be reduced and neural development was induced with time. Furthermore, effects of MeHg on neural differentiation at the gene expression level could be identified using multiple methods, including the differentiation track. MeHg was shown to specifically enhance neural differentiation-related gene expression and reduce other embryonic differentiation routes, confirming other studies and contributing further molecular information accompanying MeHg embryotoxicity. Future studies will have to show whether this model can be applied more widely for neurodevelopmental toxicity testing of chemical compounds. 
